Aug 13, 2026 04:36PM
Aug 5, 2026 07:09AM
Jul 8, 2026 07:01AM
Jun 23, 2026 06:48AM
Jun 5, 2026 07:00AM
May 5, 2026 07:33AM
Mar 2, 2026 04:06PM Seres Therapeutics names Richard Kender as interim CEO
Feb 12, 2026 07:01AM
Feb 12, 2026 06:58AM
Jan 6, 2026 07:02AM
Nov 5, 2025 07:17AM
Oct 3, 2025 04:09PM
Sep 24, 2025 06:28AM
Aug 6, 2025 07:52AM Seres Therapeutics (MCRB) Misses Q2 EPS by 218c
Jul 22, 2025 07:07AM
May 27, 2025 07:02AM
May 8, 2025 05:06AM
Mar 13, 2025 07:06AM
Mar 3, 2025 07:00AM
Jan 16, 2025 07:01AM
Dec 9, 2024 07:06AM Seres Therapeutics (MCRB) : FDA Grants Breakthrough Therapy Designation to SER-155 for Reduction of Bloodstream Infections in Adults Undergoing allo-HSCT
Nov 13, 2024 07:36AM
Oct 24, 2024 03:46AM
Oct 1, 2024 04:51PM
Sep 27, 2024 03:28PM
Sep 26, 2024 04:01PM
Sep 12, 2024 02:38PM
Sep 12, 2024 07:02AM Seres Therapeutics (MCRB) Reports SER-155 Phase 1b Placebo-Controlled Cohort 2 Study Safety and Clinical Results in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant
Aug 13, 2024 07:03AM
Aug 6, 2024 07:03AM

447,190 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All